The Dr. Tyna Show cover image

Breaking Down The Latest Sensationalism About Ozempic | Solo

The Dr. Tyna Show

00:00

Evaluating Diabetes Medications and NAION Risk

This chapter analyzes a study comparing semaglutide and SGLT2 inhibitors in relation to non-arteritic anterior ischemic optic neuropathy (NAION) risk. It highlights the limitations of the research while discussing the complexities of medication effects on vascular health, emphasizing the importance of cautious prescribing practices.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app